STOCK TITAN

CNO officer plans $222K stock sale, 4,060 shares

(Neutral)
(Neutral)
Form Type
144

Rhea-AI Filing Summary

CNO Financial Group, Inc. (CNO) is the issuer for a planned resale of common stock under Rule 144 by officer Jeanne Linnenbringer. The filing indicates an intended sale of 4,060 shares of CNO common stock through Morgan Stanley Smith Barney, with an aggregate market value of $222,207.05 and 92,521,371 shares outstanding. The securities were acquired upon vesting of performance shares during the period from February 15, 2022 through February 11, 2025. Over the prior three months, Linnenbringer sold 6,560 shares of CNO common stock for proceeds of $360,715.51.

Positive

  • None.

Negative

  • None.
Shares to be sold under Rule 144 4,060 shares Intended sale of CNO common stock by Jeanne Linnenbringer
Aggregate market value of shares to be sold $222,207.05 Planned Rule 144 sale of 4,060 CNO common shares
Shares outstanding 92,521,371 shares CNO common stock outstanding as referenced in the Form 144
Shares sold in past 3 months 6,560 shares Sales by Jeanne Linnenbringer on August 31, 2026
Proceeds from past 3 months’ sales $360,715.51 CNO shares sold by Jeanne Linnenbringer on August 31, 2026
Approximate date of intended sale September 1, 2026 Planned Rule 144 sale of 4,060 CNO shares
Rule 144 regulatory
"See the definition of "person" in paragraph (a) of Rule 144."
Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.
performance shares financial
"The securities to be sold were acquired upon the vesting of performance shares"
Performance shares are a type of company stock given to executives or employees that only become theirs if the company meets specific goals, like hitting certain profits or growth targets. They motivate leaders to work toward the company’s success, because their additional shares depend on achieving these results.
aggregate market value financial
"Common | Morgan Stanley Smith Barney LLC ... | 4060 | 222207.05 |"
Aggregate market value is the combined price you would pay to buy all outstanding shares of a company or all companies in a group at current market prices — essentially the sum of each stock’s market capitalization. It matters to investors because it shows the overall size and weight of an investment or sector (like the total cost to buy every piece of a puzzle), helps compare scale across companies or markets, and influences index composition and risk exposure.
vesting financial
"acquired upon the vesting of performance shares during the period"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.

FAQ

What does this Form 144 filing mean for CNO (CNO) shares?

The filing reports an intended sale under Rule 144 by officer Jeanne Linnenbringer of 4,060 CNO common shares, with an aggregate market value of $222,207.05. It is a notice of a potential resale of restricted or control securities, not an action by CNO itself.

How many CNO (CNO) shares does Jeanne Linnenbringer plan to sell?

Jeanne Linnenbringer plans to sell 4,060 shares of CNO common stock. The Form 144 lists these shares with an aggregate market value of $222,207.05 and identifies Morgan Stanley Smith Barney as the broker handling the potential sale.

What recent CNO (CNO) stock sales has Jeanne Linnenbringer made?

Over the past three months, Jeanne Linnenbringer sold 6,560 CNO common shares on August 31, 2026, with total proceeds of $360,715.51. These prior sales are disclosed alongside the newly intended sale under Rule 144.

How many CNO (CNO) shares are outstanding according to this filing?

The Form 144 states that 92,521,371 shares of CNO common stock are outstanding. This figure is provided as part of the Rule 144 disclosure and serves as context for the size of the proposed sale relative to total shares.

How were the CNO (CNO) shares to be sold by Jeanne Linnenbringer acquired?

The shares to be sold were acquired upon the vesting of performance shares during the period from February 15, 2022 through February 11, 2025. This is disclosed in the remarks section of the Form 144.

When is the intended sale date for the CNO (CNO) shares under this Form 144?

The approximate date of sale listed is September 1, 2026. This date applies to the intended Rule 144 sale of 4,060 CNO common shares through Morgan Stanley Smith Barney on the NYSE.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature